Search results
Is it a Good Idea to Invest in Intellia (NTLA) Stock Now?
Zacks via Yahoo Finance· 5 months agoIntellia Therapeutics, Inc. NTLA is a clinical-stage genome editing company focused on developing...
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
Motley Fool· 6 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has built a billion-dollar cystic fibrosis (CF) treatment...
Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It
Investor's Business Daily· 4 months agoSanofi is getting into the liver disease treatment space with its $1.7 billion acquisition of...
The Zacks Analyst Blog Highlights bluebird, Editas Medicine, Beam Therapeutics and Intellia...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – December 14, 2023 – Zacks.com announces the list of stocks...
Vertex Moves Its Alpha-1 Antitrypsin Deficiency Program Forward
Benzinga via Yahoo Finance· 2 years agoVertex Pharmaceuticals Inc (NASDAQ: VRTX) has advanced its investigational program targeting alpha-1...
Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease
Investor's Business Daily· 2 years agoArrowhead Pharmaceuticals has provided a bullish update for its midstage liver disease treatment,...
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?
Motley Fool· 6 months agoOn Nov. 3, Korro Bio (NASDAQ: KRRO) used Frequency Therapeutics' Nasdaq listing to reverse merge...
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
Investor's Business Daily· 2 years agoA cure for genetic diseases has been little more than a whisper — until now. Thanks to the work of...
A new non-surgical procedure is helping those with emphysema breathe better. The only problem? Not...
USA TODAY via Yahoo News· 2 years agoMILWAUKEE — About two years ago, John McLees' lungs had become so badly damaged that he could barely...
Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why
Zacks via Yahoo Finance· 2 weeks agoShares of the commercial-stage biotechnology company, Krystal Biotech, Inc. KRYS, surged 36.5% year...